Delivery Order SPE2DE24D0013-SPE2D626F5E28
- Not listed
- The Defense Logistics Agency Medical Supply Chain issued an $8,640 delivery order to Cepheid on March 12, 2026, for diagnostic supplies under a firm fixed-price structure with an ultimate completion date of March 19, 2026. Place of performance is Sunnyvale, CA 94089. The delivery order calls for molecular diagnostic testing system reagents and assays, including XPRS4PLEX-10 cartridges and related diagnostic solutions for infectious disease detection. Cepheid, headquartered in Sunnyvale,...
- The Defense Logistics Agency's Medical Supply Chain issued a $13,600 delivery order to Cepheid on March 9, 2026, for diagnostic testing supplies, with an ultimate completion date of March 16, 2026. Place of performance is Sunnyvale, CA. The order is firm fixed price with no set-aside designation. Cepheid is a for-profit manufacturer of advanced molecular diagnostic systems and reagents, headquartered in Sunnyvale, California, and serves as a primary federal supplier of diagnostic solutions to...
- The Defense Logistics Agency Medical Supply Chain issued a $13,600 delivery order to Cepheid on February 3, 2026, with ultimate completion February 10, 2026, for molecular diagnostic supplies under a firm fixed-price structure. Place of performance is Sunnyvale, CA 94089. The order calls for XPRS4PLEX-10 diagnostic cartridges and related molecular testing reagents. Cepheid, headquartered in Sunnyvale, is a manufacturer of advanced molecular diagnostic systems and reagents specializing in rapid...
- The Defense Logistics Agency Medical Supply Chain issued a $14,960 delivery order to Cepheid on March 12, 2026, for molecular diagnostic supplies, with an ultimate completion date of March 19, 2026. The order is firm fixed price with no set-aside. Place of performance is Sunnyvale, CA. Cepheid is a for-profit manufacturer of advanced molecular diagnostic systems and reagents headquartered in Sunnyvale, specializing in GeneXpert diagnostic platforms and molecular testing for infectious diseases...
- The Defense Logistics Agency Medical Supply Chain issued a $95,200 delivery order to Cepheid on March 9, 2026, for molecular diagnostic testing supplies and reagents, with performance in Sunnyvale, CA and an ultimate completion date of March 16, 2026. This is a firm fixed-price delivery order with no set-aside designation. The order calls for diagnostic testing supplies and reagents supporting Cepheid's GeneXpert diagnostic platform capabilities, which the company supplies across multiple...
- The Defense Logistics Agency Medical Supply Chain issued a delivery order to Cepheid on March 6, 2026, with a ceiling value of $35,503.20 under a firm fixed-price structure and no set-aside designation. This is a call against a parent indefinite delivery contract. Ultimate completion date is March 20, 2026. Place of performance is Sunnyvale, CA 94089. The order procures molecular diagnostic supplies and reagents—specifically GeneXpert diagnostic platform test cartridges and assays for...
- The Defense Logistics Agency Medical Supply Chain issued a $12,768.40 delivery order to Cepheid on March 6, 2026, for molecular diagnostic testing supplies under a firm fixed-price structure. Ultimate completion date is March 13, 2026. Place of performance is Sunnyvale, CA 94089. Cepheid is a manufacturer of advanced molecular diagnostic systems and reagents specializing in the GeneXpert diagnostic platform for infectious disease detection. The order calls for XPRS4PLEX-10 cartridges and related...
- The Defense Logistics Agency Medical Supply Chain issued a $20,400 delivery order to Cepheid on March 24, 2026, for diagnostic testing supplies, with final delivery on March 31, 2026. The order is firm fixed price with no set-aside. Place of performance is Sunnyvale, California. Cepheid is a for-profit manufacturer of molecular diagnostic systems and reagents specializing in GeneXpert diagnostic platforms and associated testing capabilities for infectious disease detection. The company serves as...
- The Defense Logistics Agency Medical Supply Chain issued a $6,800 delivery order to Cepheid on March 23, 2026, for diagnostic testing supplies under a firm fixed-price structure with ultimate completion by March 30, 2026. Place of performance is Sunnyvale, CA. The order carries no set-aside designation. Cepheid supplies molecular diagnostic systems, reagents, and test kits for infectious disease detection to multiple federal healthcare agencies, including the Department of Veterans Affairs,...
- The Defense Logistics Agency Medical Supply Chain issued a $49,650 delivery order to Cepheid on March 10, 2026, for diagnostic testing supplies with an ultimate completion date of March 17, 2026. Place of performance is Sunnyvale, CA. The order is firm fixed price with no set-aside. Cepheid is a for-profit manufacturer of advanced molecular diagnostic systems and reagents, headquartered in Sunnyvale, California, and a primary federal supplier of diagnostic solutions to the Department of Veterans...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F5E28Delivery Order
The Defense Logistics Agency Medical Supply Chain issued a $6,800 delivery order to Cepheid on March 24, 2026, for diagnostic testing supplies under firm fixed-price terms, with performance in Sunnyvale, CA and completion by March 31, 2026. This is a standalone delivery order with no parent IDIQ identified in the source. The order procures molecular diagnostic supplies—specifically XPRS4PLEX-10 cartridges and related reagents for the GeneXpert diagnostic platform. Cepheid, a for-profit molecular diagnostics manufacturer headquartered in Sunnyvale, California, is a primary federal supplier of rapid molecular testing systems and reagents for infectious disease detection across multiple federal healthcare agencies including the Veterans Administration, Indian Health Service, Defense Health Agency, and U.S. Coast Guard. The order carries no set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 3/23/26 |